Effect of chronic administration of a new potent agonist of GH-RH(1-29) NH2 on linear growth and GH responsiveness in rats

Jacek Pinski, Jan Izdebski, Andreas Jungwirth, Kate Groot, Andrew V Schally

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The effects of a repeated or continuous administration of a potent agonistic analog of growth hormone-releasing hormone (GH-RH), [Dat1, Thr8, Orn12,21, Abu15, Nle27, Asp28, Agm29] hGH-RH(1-29) (JI-36), on the linear growth and the GH responses to bolus injections of GH-RH(1-29)NH2 were investigated in male rats about 7 weeks old. Body weight and tail length were monitored. Basal serum GH and IGF-I concentrations and GH responses to GH-RH(1-29)NH2 were measured by RIA. Chronic administration of GH-RH agonist JI-36 by continuous release from osmotic minipumps at the rate of 0.2 μg/h or twice daily injections of 0.5 and 5 μg/rat for 4 weeks significantly speeded up the growth of rats as measured by the tail length. The acceleration of growth was similar in the 3 groups and was associated with stimulation of IGF-I secretion. The GH response to bolus injection of GH-RH(1-29)NH2 was preserved in all groups and no attenuation of the response occurred in rats treated for 4 weeks with agonist JI-36 as compared with the control group. Our results indicate that chronic administration of GH-RH agonist JI-36 significantly increases the growth rate without affecting somatotroph responsiveness in rats. It is therefore likely that this class of GH-RH agonists may be useful clinically.

Original languageEnglish
Pages (from-to)197-201
Number of pages5
JournalRegulatory Peptides
Volume65
Issue number3
DOIs
StatePublished - Sep 16 1996
Externally publishedYes

Fingerprint

Growth Hormone-Releasing Hormone
Rats
Growth
Insulin-Like Growth Factor I
Injections
Tail
Somatotrophs
Body Weight
Control Groups
Serum

Keywords

  • Growth hormone response
  • Growth hormone-releasing hormone agonist
  • Growth stimulation
  • Insulin-like growth factor I

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Neuroscience(all)

Cite this

Effect of chronic administration of a new potent agonist of GH-RH(1-29) NH2 on linear growth and GH responsiveness in rats. / Pinski, Jacek; Izdebski, Jan; Jungwirth, Andreas; Groot, Kate; Schally, Andrew V.

In: Regulatory Peptides, Vol. 65, No. 3, 16.09.1996, p. 197-201.

Research output: Contribution to journalArticle

Pinski, Jacek ; Izdebski, Jan ; Jungwirth, Andreas ; Groot, Kate ; Schally, Andrew V. / Effect of chronic administration of a new potent agonist of GH-RH(1-29) NH2 on linear growth and GH responsiveness in rats. In: Regulatory Peptides. 1996 ; Vol. 65, No. 3. pp. 197-201.
@article{b93c4d35cd9f44f9834ade57b4cc0ebc,
title = "Effect of chronic administration of a new potent agonist of GH-RH(1-29) NH2 on linear growth and GH responsiveness in rats",
abstract = "The effects of a repeated or continuous administration of a potent agonistic analog of growth hormone-releasing hormone (GH-RH), [Dat1, Thr8, Orn12,21, Abu15, Nle27, Asp28, Agm29] hGH-RH(1-29) (JI-36), on the linear growth and the GH responses to bolus injections of GH-RH(1-29)NH2 were investigated in male rats about 7 weeks old. Body weight and tail length were monitored. Basal serum GH and IGF-I concentrations and GH responses to GH-RH(1-29)NH2 were measured by RIA. Chronic administration of GH-RH agonist JI-36 by continuous release from osmotic minipumps at the rate of 0.2 μg/h or twice daily injections of 0.5 and 5 μg/rat for 4 weeks significantly speeded up the growth of rats as measured by the tail length. The acceleration of growth was similar in the 3 groups and was associated with stimulation of IGF-I secretion. The GH response to bolus injection of GH-RH(1-29)NH2 was preserved in all groups and no attenuation of the response occurred in rats treated for 4 weeks with agonist JI-36 as compared with the control group. Our results indicate that chronic administration of GH-RH agonist JI-36 significantly increases the growth rate without affecting somatotroph responsiveness in rats. It is therefore likely that this class of GH-RH agonists may be useful clinically.",
keywords = "Growth hormone response, Growth hormone-releasing hormone agonist, Growth stimulation, Insulin-like growth factor I",
author = "Jacek Pinski and Jan Izdebski and Andreas Jungwirth and Kate Groot and Schally, {Andrew V}",
year = "1996",
month = "9",
day = "16",
doi = "10.1016/S0167-0115(96)00099-7",
language = "English",
volume = "65",
pages = "197--201",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Effect of chronic administration of a new potent agonist of GH-RH(1-29) NH2 on linear growth and GH responsiveness in rats

AU - Pinski, Jacek

AU - Izdebski, Jan

AU - Jungwirth, Andreas

AU - Groot, Kate

AU - Schally, Andrew V

PY - 1996/9/16

Y1 - 1996/9/16

N2 - The effects of a repeated or continuous administration of a potent agonistic analog of growth hormone-releasing hormone (GH-RH), [Dat1, Thr8, Orn12,21, Abu15, Nle27, Asp28, Agm29] hGH-RH(1-29) (JI-36), on the linear growth and the GH responses to bolus injections of GH-RH(1-29)NH2 were investigated in male rats about 7 weeks old. Body weight and tail length were monitored. Basal serum GH and IGF-I concentrations and GH responses to GH-RH(1-29)NH2 were measured by RIA. Chronic administration of GH-RH agonist JI-36 by continuous release from osmotic minipumps at the rate of 0.2 μg/h or twice daily injections of 0.5 and 5 μg/rat for 4 weeks significantly speeded up the growth of rats as measured by the tail length. The acceleration of growth was similar in the 3 groups and was associated with stimulation of IGF-I secretion. The GH response to bolus injection of GH-RH(1-29)NH2 was preserved in all groups and no attenuation of the response occurred in rats treated for 4 weeks with agonist JI-36 as compared with the control group. Our results indicate that chronic administration of GH-RH agonist JI-36 significantly increases the growth rate without affecting somatotroph responsiveness in rats. It is therefore likely that this class of GH-RH agonists may be useful clinically.

AB - The effects of a repeated or continuous administration of a potent agonistic analog of growth hormone-releasing hormone (GH-RH), [Dat1, Thr8, Orn12,21, Abu15, Nle27, Asp28, Agm29] hGH-RH(1-29) (JI-36), on the linear growth and the GH responses to bolus injections of GH-RH(1-29)NH2 were investigated in male rats about 7 weeks old. Body weight and tail length were monitored. Basal serum GH and IGF-I concentrations and GH responses to GH-RH(1-29)NH2 were measured by RIA. Chronic administration of GH-RH agonist JI-36 by continuous release from osmotic minipumps at the rate of 0.2 μg/h or twice daily injections of 0.5 and 5 μg/rat for 4 weeks significantly speeded up the growth of rats as measured by the tail length. The acceleration of growth was similar in the 3 groups and was associated with stimulation of IGF-I secretion. The GH response to bolus injection of GH-RH(1-29)NH2 was preserved in all groups and no attenuation of the response occurred in rats treated for 4 weeks with agonist JI-36 as compared with the control group. Our results indicate that chronic administration of GH-RH agonist JI-36 significantly increases the growth rate without affecting somatotroph responsiveness in rats. It is therefore likely that this class of GH-RH agonists may be useful clinically.

KW - Growth hormone response

KW - Growth hormone-releasing hormone agonist

KW - Growth stimulation

KW - Insulin-like growth factor I

UR - http://www.scopus.com/inward/record.url?scp=0030590422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030590422&partnerID=8YFLogxK

U2 - 10.1016/S0167-0115(96)00099-7

DO - 10.1016/S0167-0115(96)00099-7

M3 - Article

C2 - 8897642

AN - SCOPUS:0030590422

VL - 65

SP - 197

EP - 201

JO - Regulatory Peptides

JF - Regulatory Peptides

SN - 0167-0115

IS - 3

ER -